High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo
OBJECTIVE—To investigate whether high-density lipoproteins (HDLs) suppress chemokine (CCL2, CCL5, and CX3CL1) and chemokine receptor (CCR2 and CX3CR1) expression, a mechanism for the atheroprotective properties of HDLs. METHODS AND RESULTS—Apolipoprotein (apo) E mice were fed a high-fat diet for 12...
Gespeichert in:
Veröffentlicht in: | Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2010-09, Vol.30 (9), p.1773-1778 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVE—To investigate whether high-density lipoproteins (HDLs) suppress chemokine (CCL2, CCL5, and CX3CL1) and chemokine receptor (CCR2 and CX3CR1) expression, a mechanism for the atheroprotective properties of HDLs.
METHODS AND RESULTS—Apolipoprotein (apo) E mice were fed a high-fat diet for 12 weeks. Before being euthanized, the mice received 5 consecutive daily injections of lipid-free apoA-I, 40 mg/kg, or saline (control). The injection of apoA-I reduced CCR2 and CX3CR1 expression in plaques compared with controls (P |
---|---|
ISSN: | 1079-5642 1524-4636 |
DOI: | 10.1161/ATVBAHA.110.211342 |